Glaukos (GKOS)
(Delayed Data from NYSE)
$82.10 USD
-0.25 (-0.30%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $82.17 +0.07 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GKOS 82.10 -0.25(-0.30%)
Will GKOS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GKOS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GKOS
Glaukos Builds Dual Growth Engines Amid Market Headwinds
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
GKOS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates
Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks
What Makes Glaukos (GKOS) a New Buy Stock
Other News for GKOS
Needham medtech & diagnostics analysts hold analyst/industry conference call
Is GKOS ready to move higher? Stochastic Buy Signal shows up after gaining 2.12%
Needham medtech & diagnostics analysts hold analyst/industry conference call
Glaukos (GKOS) Gains Positive Attention from Stifel Analyst
Stifel sees opportunity in Glaukos selloff, adds to Select List